22-50246343-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032019.6(HDAC10):āc.1605G>Cā(p.Glu535Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,612,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032019.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HDAC10 | NM_032019.6 | c.1605G>C | p.Glu535Asp | missense_variant | 17/20 | ENST00000216271.10 | |
HDAC10 | NM_001159286.2 | c.1545G>C | p.Glu515Asp | missense_variant | 16/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HDAC10 | ENST00000216271.10 | c.1605G>C | p.Glu535Asp | missense_variant | 17/20 | 1 | NM_032019.6 | P1 | |
ENST00000685176.2 | n.1707C>G | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.0000722 AC: 11AN: 152264Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 250330Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135432
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460596Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 726622
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152382Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74514
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.1605G>C (p.E535D) alteration is located in exon 17 (coding exon 17) of the HDAC10 gene. This alteration results from a G to C substitution at nucleotide position 1605, causing the glutamic acid (E) at amino acid position 535 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at